- To review the updates in immunopathogenesis, genetics, and clinical features of hemophagocytic syndrome
- To examine the available tools and biomarkers in effective diagnostic approach to macrophage activation syndrome.
- To Identify the effective therapeutic approach for optimal outcome.
- To integrate knowledge from MAS in immune adjuvant therapy in sepsis.
- 1.00 AMA PRA Category 1 Credit(s)™
- 1.00 Attendance